Rationale and design of the FAIR‐HF2‐DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure.
Saved in:
| Title: | Rationale and design of the FAIR‐HF2‐DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure. |
|---|---|
| Authors: | Anker, Stefan D.1,2 (AUTHOR) s.anker@cachexia.de, Friede, Tim3 (AUTHOR), Butler, Javed4,5 (AUTHOR), Talha, Khawaja M.6 (AUTHOR), Diek, Monika1 (AUTHOR), Nosko, Anna7,8 (AUTHOR), Placzek, Marius3 (AUTHOR), Hasenfuß, Gerd9 (AUTHOR), Ponikowski, Piotr10 (AUTHOR), Karakas, Mahir7,8 (AUTHOR) m.karakas@uke.de |
| Source: | European Journal of Heart Failure. Apr2025, Vol. 27 Issue 4, p681-689. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1002/ejhf.3574 |
